DRKS00023929
Completed
Not Applicable
Plasma biomarkers for prediction of early tumor recurrence after resection of pancreatic ductal adenocarcinoma
Allgemein- und Viszeralchirurgie Uniklinik Freiburg0 sites14 target enrollmentDecember 27, 2020
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- C25
- Sponsor
- Allgemein- und Viszeralchirurgie Uniklinik Freiburg
- Enrollment
- 14
- Status
- Completed
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Primary resectable pancreatic ductal adenocarcinoma
Exclusion Criteria
- •Other tumor entities in pt. history
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Not Applicable
Identification of predictive plasma Biomarkers and use of a high dosage statin during a procedure of Parrossistic Atrial Fibrillation CardioversioEUCTR2012-001260-29-ITFONDAZIONE ISTITUTO SAN RAFFAELE-G.GIGLIO
Completed
Not Applicable
Circulating Tumor Cells as a Biomarker for Preoperative Prognostic Staging in Patients With Esophageal CancerResectable Esophageal CancerNCT01858805Universitätsklinikum Hamburg-Eppendorf123
Completed
Not Applicable
CA209-759: Blood-borne biomarkers for tumor response to Nivolumab in KRAS-mutated non-small cell lung cancer, an exploratory studyNon-small cell lung cancer (NSCLC)10038666NL-OMON45880niversitair Medisch Centrum Groningen40
Not yet recruiting
Not Applicable
CA209-759: Blood-borne biomarkers for tumor response to Nivolumab in KRAS-mutated non-small cell lung canceron-small cell lung cancer, KRAS mutationNiet-kleincellig longkanker, KRAS mutatieNL-OMON25545niversity Medical Center Groningen40
Completed
Not Applicable
INTENT_Circulating tumor cells as biomarkers for recurrence risk in thermoablatioC22.0Liver cell carcinomaDRKS00016808Klinikum der Universität München, Campus Großhadern100